European union faces shortfall of AstraZeneca vaccine

The European Union is facing a further shortfall in its Coronavirus inoculation program. This after the pharmaceutical giant AstraZeneca said that production problems and experts restrictions would reduce plan deliveries of its vaccine. Several countries have suspended the AstraZeneca vaccine over blood clot fears. ‌